Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H26N2O3 |
Molecular Weight | 414.4962 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]15CCN(CC6CC6)[C@H](C4)[C@]5(O)CC7=C2NC8=C7C=CC=C8
InChI
InChIKey=WIYUZYBFCWCCQJ-IFKAHUTRSA-N
InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1
Molecular Formula | C26H26N2O3 |
Molecular Weight | 414.4962 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Naltrindole is a highly potent, highly selective delta opioid receptor antagonist. It is predominantly used as a molecular probe in biomedical studies exploring the manipulation of delta opioid receptors. Naltrindole was shown to inhibit cancer cell growth in vitro; potentially through a nonopioid receptor-dependant mechanism.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2169936
Curator's Comment: the referenced study was conducted on rats
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P32300 Gene ID: 18386.0 Gene Symbol: Oprd1 Target Organism: Mus musculus (Mouse) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22596164 |
37.0 pM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 1994 Feb |
|
Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death. | 1997 |
|
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. | 1998 Mar |
|
Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. | 2001 Sep |
|
Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. | 2005 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2169936
Curator's Comment: the referenced study was conducted on rats
Naltrindole (0.5 and 1 mg/kg) antagonized swim-stress-induced antinociception in adult and 25-day old rats; but in 20-day old rats, naltrindole (1 mg/kg) had no effect.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27391529
Curator's Comment: referenced study was conducted on boar
Stock solutions of Naltrindole were thawed and diluted in Beltsville-Thawing Solution to 200 micro-M. Three 1:10 serial dilutions were made in Beltsville-Thawing Solution. Subsequently, 200 micro-L of standardized Boar Sperm was added to 200 micro-L of Naltrindole solution. The final concentration of Naltrindole was 100, 10, and 1 micro-M. The Naltrindole-Sperm mixtures were incubated at 38 deg-C with shaking, and 25 micro-L aliquots were sampled at 5, 10, 15, 30, and 60 minutes. each aliquot was analyzed for membrane and mitochondrial integrity, including signs of early destabilization, as well as sperm kinematics. Naltrindole did not affect sperm motility at any concentration. However, the highest concentration of naltrindole (100 micro-M) caused a significant decrease in sperm viability after 60 minutes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:53:12 GMT 2023
by
admin
on
Sat Dec 16 09:53:12 GMT 2023
|
Record UNII |
G167Z38QA4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
111555-53-4
Created by
admin on Sat Dec 16 09:53:12 GMT 2023 , Edited by admin on Sat Dec 16 09:53:12 GMT 2023
|
PRIMARY | |||
|
Naltrindole
Created by
admin on Sat Dec 16 09:53:12 GMT 2023 , Edited by admin on Sat Dec 16 09:53:12 GMT 2023
|
PRIMARY | |||
|
G167Z38QA4
Created by
admin on Sat Dec 16 09:53:12 GMT 2023 , Edited by admin on Sat Dec 16 09:53:12 GMT 2023
|
PRIMARY | |||
|
DTXSID60912216
Created by
admin on Sat Dec 16 09:53:12 GMT 2023 , Edited by admin on Sat Dec 16 09:53:12 GMT 2023
|
PRIMARY | |||
|
5497186
Created by
admin on Sat Dec 16 09:53:12 GMT 2023 , Edited by admin on Sat Dec 16 09:53:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DERIVATIVE -> PARENT | |||
|
TARGET -> INHIBITOR |
|